Abstract
Amniotic membrane, the inner layer of the placenta, has biological properties (e.g. promotes epithelization, reduces fibrosis, secretes antimicrobial products and inhibits immune responses) which make it a useful option for several ophthalmologic procedures, especially those involving the ocular surface. Its use in eye surgery has been reported by other authors. To our knowledge, there is a lack of descriptive studies on surgical indications using amniotic membrane in Mexican population. Here we describe the eight years Amniotic Membrane Bank experience in Mexico, including a detailed protocol of the donors selection, tissue harvesting, preparation, storage and distribution of amniotic membrane since its establishment in 2007. Moreover, we describe the Ophthalmological indications of amniotic membrane transplantation of the total of 1686 amniotic membranes fragments used during eight years. The five most common indications for amniotic membrane transplantation were pterygium (46 %), corneal ulcers (12.6 %), conjunctival surface repair (11.1 %), neoplasms (7.4 %), and persistent epithelial defects (7.3 %). In addition, we compared the indications of amniotic membrane use in two different types of Institutions: general hospitals and ophthalmologic reference hospitals. We found interesting differences between the indications and use rates between these institutions, although pterygium was the most frequent pathology that amniotic membrane fragments were used in both institutions, there was up to a five-fold increase in the use of amniotic membrane for correction of persistent epithelial defects in reference hospitals which could be explained due to the more complex and severe ophthalmological pathologies admitted in reference hospitals. In conclusion, Amniotic Membrane is used in a numerous ocular pathologies and especially on pterygium in our Mexican population.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Burman S, Tejwani S, Vemuganti GK, Gopinathan U, Sangwan VS (2004) Ophthalmic applications of preserved human amniotic membrane: a review of current indications. Cell Tissue Bank 5:161–175. doi:10.1023/B:CATB.0000046067.25057.0a
Busch MP et al (2005) A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 45:254–264. doi:10.1111/j.1537-2995.2004.04215.x
Cirman T, Beltram M, Schollmayer P, Rozman P, Kreft ME (2014) Amniotic membrane properties and current practice of amniotic membrane use in ophthalmology in Slovenia. Cell Tissue Bank 15:177–192. doi:10.1007/s10561-013-9417-6
Dominguez-Lopez A, Bautista de Lucio VM, Serafin-Lopez J, Robles-Sanchez E, Garfias Y (2014) Amniotic membrane modulates innate immune response inhibiting PRRs expression and NF-kappaB nuclear translocation on limbal myofibroblasts. Exp Eye Res 127:215–223. doi:10.1016/j.exer.2014.08.002
Dua HS, Gomes JA, King AJ, Maharajan VS (2004) The amniotic membrane in ophthalmology. Surv Ophthalmol 49:51–77
Esther Martinez-Pardo M, Lourdes Reyes-Frias M (2003) The tissue bank at the national nuclear research institute in Mexico. Cell Tissue Bank 4:163–168. doi:10.1023/B:CATB.0000007038.09698.c2
Garfias Y, Zaga-Clavellina V, Vadillo-Ortega F, Osorio M, Jimenez-Martinez MC (2011) Amniotic membrane is an immunosuppressor of peripheral blood mononuclear cells. Immunol Invest 40:183–196. doi:10.3109/08820139.2010.532266
Holzman C, Senagore PK, Wang J (2013) Mononuclear leukocyte infiltrate in extraplacental membranes and preterm delivery. Am J Epidemiol 177:1053–1064. doi:10.1093/aje/kws351
Laurent R, Nallet A, Obert L, Nicod L, Gindraux F (2014) Storage and qualification of viable intact human amniotic graft and technology transfer to a tissue bank. Cell Tissue Bank 15:267–275. doi:10.1007/s10561-014-9437-x
Madhavan HN, Priya K, Malathi J, Joseph PR (2002) Preparation of amniotic membrane for ocular surface reconstruction. Indian J Ophthalmol 50:227–231
Mamede AC, Carvalho MJ, Abrantes AM, Laranjo M, Maia CJ, Botelho MF (2012) Amniotic membrane: from structure and functions to clinical applications. Cell Tissue Res 349:447–458. doi:10.1007/s00441-012-1424-6
Mariappan I et al (2010) In vitro culture and expansion of human limbal epithelial cells. Nat Protoc 5:1470–1479. doi:10.1038/nprot.2010.115
Nava-Castaneda A, Ulloa-Orozco I, Garnica-Hayashi L, Hernandez-Orgaz J, Jimenez-Martinez MC, Garfias Y (2015) Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up. J Ocul Pharmacol Ther 31:106–113. doi:10.1089/jop.2014.0060
Osman I, Young A, Ledingham MA, Thomson AJ, Jordan F, Greer IA, Norman JE (2003) Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod 9:41–45
Paolin A, Cogliati E, Trojan D, Griffoni C, Grassetto A, Elbadawy HM, Ponzin D (2015) Amniotic membranes in ophthalmology: long term data on transplantation outcomes. Cell Tissue Bank. doi:10.1007/s10561-015-9520-y
Rahman I, Said DG, Maharajan VS, Dua HS (2009) Amniotic membrane in ophthalmology: indications and limitations. Eye (Lond) 23:1954–1961. doi:10.1038/eye.2008.410
Riau AK, Beuerman RW, Lim LS, Mehta JS (2010) Preservation, sterilization and de-epithelialization of human amniotic membrane for use in ocular surface reconstruction. Biomaterials 31:216–225. doi:10.1016/j.biomaterials.2009.09.034
Sant’Anna LB, Cargnoni A, Ressel L, Vanosi G, Parolini O (2011) Amniotic membrane application reduces liver fibrosis in a bile duct ligation rat model. Cell Transplant 20:441–453. doi:10.3727/096368910X522252
Stock SJ, Kelly RW, Riley SC, Calder AA (2007) Natural antimicrobial production by the amnion. Am J Obstet Gynecol 196(255):e251–e256. doi:10.1016/j.ajog.2006.10.908
Thomasen H et al (2011) The effect of long-term storage on the biological and histological properties of cryopreserved amniotic membrane. Curr Eye Res 36:247–255. doi:10.3109/02713683.2010.542267
Weusten J, Vermeulen M, van Drimmelen H, Lelie N (2011) Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms. Transfusion 51:203–215. doi:10.1111/j.1537-2995.2010.02804.x
Yang PT, Sharpen L, Chan A, Chan CC (2014) Indications for amniotic membrane grafts used in Ontario from 2011 to 2012. Can J Ophthalmol 49:399. doi:10.1016/j.jcjo.2014.05.006
Acknowledgments
The authors wish to thank Dr. Mohamed Jarraya for his helpful suggestions in improving this manuscript. This work was supported by CONACYT-SALUD-2004-C01-096, CONACYT-SALUD-2011-C01-160286, Conde de Valenciana Foundation, and the Instituto Nacional de Perinatología Isidro Espinosa de los Reyes.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chávez-García, C., Jiménez-Corona, A., Graue-Hernández, E.O. et al. Ophthalmic indications of amniotic membrane transplantation in Mexico: an eight years Amniotic Membrane Bank experience. Cell Tissue Bank 17, 261–268 (2016). https://doi.org/10.1007/s10561-015-9540-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-015-9540-7